Fluorine-19 NMR of integral membrane proteins illustrated with studies of GPCRs

Current Opinion in Structural Biology

Volumn 23, Issue 5, 2013, Pages 740-747

  Didenko, Tatiana ^a   Liu, Jeffrey J ^a   Horst, Reto ^a,b   Stevens, Raymond C ^a   Wüthrich, Kurt ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,2,2 TRIFLUOROETHANETHIOL; 3 BROMO 1,1,1 TRIFLUOROACETONE; 4 (PERFLUORO TERT BUTYL)PHENYLIODOCETAMIDE; AMINO ACID; AMINO ACID DERIVATIVE; BACTERIORHODOPSIN; BETA 2 ADRENERGIC RECEPTOR; CIC EC1 CHLORIDE PROTEIN ANTIPORTER; DEXTRO LACTATE DEHYDROGENASE; DIACYLGLYCEROL KINASE; FLUORINE; G PROTEIN COUPLED RECEPTOR; GRAMICIDIN A; M13 PHAGE COAT PROTEIN; MEMBRANE PROTEIN; POLYPEPTIDE; REAGENT; RHODOPSIN; S ETHYL TRIFLUOROTHIOACETATE; TRIFLUOROETHANOL; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; BIOSYNTHETIC INCORPORATION; CHEMICAL ENVIRONMENT; CHEMICAL REACTION; CONFORMATION; CONJUGATION; CRYSTAL STRUCTURE; DRUG BINDING SITE; FLUORINE NUCLEAR MAGNETIC RESONANCE; HUMAN; IMMERSION; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECEPTOR ACTIVATION; REVIEW; SEQUENCE SPECIFIC INCORPORATION; SITE DIRECTED MUTAGENESIS; THREE DIMENSIONAL PROTEIN STRUCTURE;

FLUORINE RADIOISOTOPES; MEMBRANE PROTEINS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84885846349     PISSN: 0959440X     EISSN: 1879033X     Source Type: Journal    
DOI: 10.1016/j.sbi.2013.07.011     Document Type: Review

References (56)

1. Mooney E., Winson P. Fluorine-19 nuclear magnetic resonance spectroscopy. Annu Rep NMR Spectrosc 1968, 1:243-311.
2. Dolbier W.R. Guide to Fluorine NMR for Organic Chemists 2009, Wiley, Hoboken, NJ.
3. Gerig J.T. Fluorine NMR of proteins. Prog Nucl Mag Res Spectrosc 1994, 26:293-370.
4. Sykes B.D., Hull W.E. Fluorine nuclear magnetic resonance studies of proteins. Methods Enzymol 1978, 49:270-295.
5. Cobb S.L., Murphy C.D. F-19 NMR applications in chemical biology. J Fluorine Chem 2009, 130:132-143.
6. Kitevski-LeBlanc J.L., Prosser R.S. Current applications of F-19 NMR to studies of protein structure and dynamics. Prog Nucl Mag Res Spectrosc 2012, 62:1-33.
7. Hagen D.S., Weiner J.H., Sykes B.D. Fluorotyrosine M13 coat protein: fluorine-19 nuclear magnetic resonance study of the motional properties of an integral membrane protein in phospholipid vesicles. Biochemistry 1978, 17:3860-3866.
8. Wilson M.L., Dahlquist F.W. Membrane protein conformational change dependent on the hydrophobic environment. Biochemistry 1985, 24:1920-1928.
9. 19F nuclear magnetic resonance study. Proc Natl Acad Sci U S A 1979, 76:4230-4234.
10. Weinstein S., Durkin J.T., Veatch W.R., Blout E.R. Conformation of the gramicidin A channel in phospholipid vesicles: a fluorine-19 nuclear magnetic resonance study. Biochemistry 1985, 24:4374-4382.
11. Ho C., Rule G.S., Pratt E.A. Nuclear magnetic resonance, biochemical, and molecular genetic studies of the membrane-bound d-lactate dehydrogenase of Escherichia coli. Biophys J 1986, 49:113-115.
12. 19F-NMR study of the equilibrium unfolding of membrane-associated d-lactate dehydrogenase of Escherichia coli. Biochemistry 1996, 35:16502-16509.
13. Arseniev A.S., Kuryatov A.B., Tsetlin V.I., Bystrov V.F., Ivanov V.T., Ovchinnikov Y.A. F-19-NMR study of 5-fluorotryptophan-labeled bacteriorhodopsin. FEBS Lett 1987, 213:283-288.
14. 19F NMR. Proc Natl Acad Sci U S A 1999, 96:13744-13749.
15. 19F nuclear Overhauser effects in structural studies of the cytoplasmic domain of mammalian rhodopsin. Proc Natl Acad Sci U S A 2001, 98:4888-4892.
16. Luchette P.A., Prosser R.S., Sanders C.R. Oxygen as a paramagnetic probe of membrane protein structure by cysteine mutagenesis and F-19 NMR spectroscopy. J Am Chem Soc 2002, 124:1778-1781.
17. Elvington S.M., Liu C.W., Maduke M.C. Substrate-driven conformational changes in ClC-ec1 observed by fluorine NMR. EMBO J 2009, 28:3090-3102.
18. 19F-NMR. Science 2012, 335:1106-1110.
19. Chung K.Y., Kim T.H., Manglik A., Alvares R., Kobilka B.K., Prosser R.S. Role of detergents in conformational exchange of a G protein-coupled receptor. J Biol Chem 2012, 287:36305-36311.
20. Horst R., Liu J.J., Stevens R.C., Wüthrich K. β2-adrenergic receptor activation by agonists studied with 19F-NMR. Angew Chem 2013, 10.1002/anie.201305286.
21. Kim T.H., Chung K.Y., Manglik A., Hansen A.L., Dror R.O., Mildorf T.J., Shaw D.E., Kobilka B.K., Prosser R.S. The role of ligands on the equilibria between functional states of a G protein-coupled receptor. J Am Chem Soc 2013, 135:9465-9474.
22. Stevens R.C., Cherezov V., Katritch V., Abagyan R., Kuhn P., Rosen H., Wüthrich K. The GPCR Network: a large-scale collaboration to determine human GPCR structure and function. Nat Rev Drug Discov 2013, 12:25-34.
23. White S.H. Biophysical dissection of membrane proteins. Nature 2009, 459:344-346.
24. 19F multidimensional NMR. Prog Nucl Mag Res Spectrosc 2006, 48:1-23.
25. Li H., Frieden C. Fluorine-19 NMR studies on the acid state of the intestinal fatty acid binding protein. Biochemistry 2006, 45:6272-6278.
26. 1H NMR. J Biomol NMR 1995, 5:415-419.
27. Feeney J., McCormick J.E., Bauer C.J., Birdsall B., Moody C.M., Starkmann B.A., Young D.W., Francis P., Havlin R.H., Arnold W.D., Oldfield E. F-19 nuclear magnetic resonance chemical shifts of fluorine containing aliphatic amino acids in proteins: Studies on Lactobacillus casei dihydrofolate reductase containing (2S,4S)-5-fluoroleucine. J Am Chem Soc 1996, 118:8700-8706.
28. Kitevski-LeBlanc J.L., Al-Abdul-Wahid M.S., Prosser R.S. A mutagenesis-free approach to assignment of F-19 NMR resonances in biosynthetically labeled proteins. J Am Chem Soc 2009, 131:2054-2055.
29. Kitevski-LeBlanc J.L., Evanics F., Prosser R.S. Approaches to the assignment of F-19 resonances from 3-fluorophenylalanine labeled calmodulin using solution state NMR. J Biomol NMR 2010, 47:113-123.
30. 19F NMR studies of solvent exposure and peptide binding to an SH3 domain. Biochim Biophys Acta 2007, 1770:221-230.
31. Hagen D.S., Weiner J.H., Sykes B.D. Investigation of solvent accessibility of the fluorotyrosyl residues of M13 coat protein in deoxycholate micelles and phospholipid vesicles. Biochemistry 1979, 18:2007-2012.
32. 19F NMR. Proc Natl Acad Sci U S A 2000, 97:9967-9971.
33. Lau E.Y., Gerig J.T. Origins of fluorine NMR chemical shifts in fluorine-containing proteins. J Am Chem Soc 2000, 122:4408-4417.
34. Kalbitzer H.R., Rohr G., Nowak E., Goody R.S., Kuhn W., Zimmermann H. A new high-sensitivity F-19 probe for labeling cysteine groups of proteins. NMR Biomed 1992, 5:347-350.
35. Mehta V.D., Kulkarni P.V., Mason R.P., Constantinescu A., Antich P.P. Fluorinated proteins as potential F-19 magnetic-resonance-imaging and spectroscopy agents. Bioconjug Chem 1994, 5:257-261.
36. 19F nuclear spin relaxation mechanism in proteins. J Mol Biol 1975, 98:121-153.
37. Frieden C., Hoeltzli S.D., Bann J.G. The preparation of F-19-labeled proteins for NMR studies. Method Enzymol 2004, 380:400-415.
38. Alexeev D., Barlow P.N., Bury S.M., Charrier J.D., Cooper A., Hadfield D., Jamieson C., Kelly S.M., Layfield R., Mayer R.J., McSparron H., Price N.C., Ramage R., Sawyer L., Starkmann B.A., Uhrin D., Wilken J., Young D.W. Synthesis, structural and biological studies of ubiquitin mutants containing (2S, 4S)-5-fluoroleucine residues strategically placed in the hydrophobic core. ChemBioChem 2003, 4:894-896.
39. Jones D.H., Cellitti S.E., Hao X., Zhang Q., Jahnz M., Summerer D., Schultz P.G., Uno T., Geierstanger B.H. Site-specific labeling of proteins with NMR-active unnatural amino acids. J Biomol NMR 2010, 46:89-100.
40. Cellitti S.E., Jones D.H., Lagpacan L., Hao X., Zhang Q., Hu H., Brittain S.M., Brinker A., Caldwell J., Bursulaya B., Spraggon G., Brock A., Ryu Y., Uno T., Schultz P.G., Geierstanger B.H. In vivo incorporation of unnatural amino acids to probe structure, dynamics, and ligand binding in a large protein by nuclear magnetic resonance spectroscopy. J Am Chem Soc 2008, 130:9268-9281.
41. Jackson J.C., Hammill J.T., Mehl R.A. Site-specific incorporation of a (19)F-amino acid into proteins as an NMR probe for characterizing protein structure and reactivity. J Am Chem Soc 2007, 129:1160-1166.
42. 19F-NMR structural characterization. Nat Protoc 2007, 2:2601-2607.
43. Shi P., Wang H., Xi Z., Shi C., Xiong Y., Tian C. Site-specific (19)F NMR chemical shift and side chain relaxation analysis of a membrane protein labeled with an unnatural amino acid. Protein Sci 2011, 20:224-228.
44. Li C., Wang G.F., Wang Y., Creager-Allen R., Lutz E.A., Scronce H., Slade K.M., Ruf R.A., Mehl R.A., Pielak G.J. Protein (19)F NMR in Escherichia coli. J Am Chem Soc 2010, 132:321-327.
45. Krogh A., Larsson B., von Heijne G., Sonnhammer E.L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 2001, 305:567-580.
46. Fagerberg L., Jonasson K., von Heijne G., Uhlen M., Berglund L. Prediction of the human membrane proteome. Proteomics 2010, 10:1141-1149.
47. Hopkins A.L., Groom C.R. The druggable genome. Nat Rev Drug Discov 2002, 1:727-730.
48. Russ A.P., Lampel S. The druggable genome: an update. Drug Discov Today 2005, 10:1607-1610.
49. Overington J.P., Al-Lazikani B., Hopkins A.L. How many drug targets are there?. Nat Rev Drug Discov 2006, 5:993-996.
50. Liu W., Chun E., Thompson A.A., Chubukov P., Xu F., Katritch V., Han G.W., Roth C.B., Heitman L.H., IJzerman A.P., Cherezov V., Stevens R.C. Structural basis for allosteric regulation of GPCRs by sodium ions. Science 2012, 337:232-236.
51. Hanson M.A., Cherezov V., Griffith M.T., Roth C.B., Jaakola V.P., Chien E.Y., Velasquez J., Kuhn P., Stevens R.C. A specific cholesterol binding site is established by the 2.8Å structure of the human beta2-adrenergic receptor. Structure 2008, 16:897-905.
52. Urban J.D., Clarke W.P., von Zastrow M., Nichols D.E., Kobilka B., Weinstein H., Javitch J.A., Roth B.L., Christopoulos A., Sexton P.M., Miller K.J., Spedding M., Mailman R.B. Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 2007, 320:1-13.
53. Rasmussen S.G., DeVree B.T., Zou Y., Kruse A.C., Chung K.Y., Kobilka T.S., Thian F.S., Chae P.S., Pardon E., Calinski D., Mathiesen J.M., Shah S.T., Lyons J.A., Caffrey M., Gellman S.H., Steyaert J., Skiniotis G., Weis W.I., Sunahara R.K., Kobilka B.K. Crystal structure of the β2-adrenergic receptor-Gs protein complex. Nature 2011, 477:549-555.
54. 19F into the center of GB1: effects on structure and stability. FEBS Lett 2002, 517:55-60.
55. Li H.L., Frieden C. Observation of sequential steps in the folding of intestinal fatty acid binding protein using a slow folding mutant and F-19 NMR. Proc Natl Acad Sci U S A 2007, 104:11993-11998.
56. Xiao G.Y., Parsons J.F., Tesh K., Armstrong R.N., Gilliland G.L. Conformational changes in the crystal structure of rat glutathione transferase M1-1 with global substitution of 3-fluorotyrosine for tyrosine. J Mol Biol 1998, 281:323-339.